Sign inJoin waitlistJoin the waitlist

Peter Vu

Medical Director, Cancer Quality · University of California (San Diego) Medical Center

Credentials: · · · · ·

History

Cancer Quality · University of California (San Diego) Medical Center
Present
University of California (San Diego) Medical Center
Present

University of California-San Diego
2017–2019
Internal Medicine
2014–2017
Doctor of Medicine
2010–2014

Research

Disparities in telemedicine during COVID-19
Cancer Medicine · 2022 · 101 citations
Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced…
JCO Precision Oncology · 2019 · 56 citations
NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024
Journal of the National Comprehensive Cancer Network · 2024 · 41 citations

Sandip Patel
4 papers
AG
Aaron Goodman
2 papers
Kathryn Gold
2 papers
Razelle Kurzrock
2 papers
Aaron Miller
1 paper
Ah-Reum Jeong
1 paper
Alan Venook
1 paper
Alexander Qian
1 paper
Angela Alistar
1 paper
Anne Walling
1 paper
AM
Arnold Markowitz
1 paper
Audrey Lazenby
1 paper

Clinical trials

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
Principal investigator · Recruiting · Phase 1, Phase 2
University of California, San Diego
2026–2033
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2023–2030